Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P0LD
|
|||
| Drug Name |
Efgartigimod alfa
|
|||
| Synonyms |
Efgartigimod
Click to Show/Hide
|
|||
| Indication | Myasthenia gravis [ICD-11: 8C6Y] | Approved | [1] | |
| Company |
Argenx
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Neonatal Fc receptor (FCGRT) | Target Info | Blocker | [1] |
| NetPath Pathway | TCR Signaling Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761195. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.